{"ticker": {"uuid": "0f921907-eedb-45c0-82dd-e68e2e178635", "symbol": "OSRH", "name": "OSR Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Form DEF 14A OSR Holdings Inc For: 16 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOMl9rMnJHMy0yRkgzNkxOX3pTSUJPcVlrNlJGZl9nRGFFLWl2cXRkMTVQRkdmNmVBQzVUVjh5OGI1T2xJVnVMVHFkeDVGaktuRHN3TW5RY2Fpb1BQY2ZIQnJSd0c3YklGZkZXanhieWJlb0p1Sjc1cXFwMXZjYWV1Mng2Sml1RmhjNHFaRVFsdlBxZWVNUEJIS2ZBZHJhb2xWTHdtVQ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-16T21:12:05+00:00", "published_display": "16 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OSR Health (NASDAQ: OSRH) asks shareholders to approve a 150M share increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOOC1zc0pyMWJsLThfS0NiZEhndHYwS1JFY0FjdFVleFRlMzZNLVlERkFwRjhmdU1DaTlYWmJlbUxPb0JLTkp1LXpiRUNsOG5NbWJ3NzJPV3U0V2FUZDhGUzRWWFZRZFA0dS1vTVZMdHBJTlJtZ1NQempBN2NLc0R6SjAySG5fdEY4Vk1jd05WYmhBeFF3OFdUX082ZlZiWjIwdzVmVXJ3QVhaTFhvTlZLY1dn?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSR Health, Inc. Actuals & Estimates (NASDAQ:OSRH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNUTVlN2E3ZXAtVjZIRWx4NHFrR2pmWngwRkxMM2JQUGhuZzlzeWprMEh4WW1qeERJY2tTN2FITWdMV3FkWWlwWWl5MlpWSXZHWTFMRFJ0SklOX0lwdDRWdE5McHJ2R0pNWEFaM1ZyUl9mZ0RIMUxrb2ZKN2EwVFFYR1dmeHB2QQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T08:55:26+00:00", "published_display": "26 Jun 2026 08:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2025-04-03T07:00:00+00:00", "published_display": "03 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bellevue Life Sciences Acquisition Corp. (BLAC) to Combine with OSR Holdings", "summary": "Bellevue Life Sciences (NASDAQ:BLAC) has entered into a definitive agreement to combine with OSR Holdings, a Korean healthcare holding company. This merger involves a sponsor entity merging with itself, as both Bellevue and OSR share CEO Peter Kuk Hyoun Hwang, who is also the fou", "url": "https://www.spacinsider.com/news/deal-announcements-amendments/bellevue-life-sciences-blac-to-combine-with-osr-holdings", "source_name": "SPACInsider", "published_at": "2023-11-17T11:14:00", "published_display": "17 Nov 2023 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "sector", "tier_label": "Sector context"}, {"title": "Bellevue Life Sciences Acquisition (BLAC) 10K Form and Latest SEC Filings 2026", "summary": "This article provides an overview of OSR Holdings, Inc.'s (NASDAQ: OSRH) SEC filings, highlighting that the company has submitted over 133 documents since 2022. It details different types of SEC filings such as 10-K, 10-Q, and 8-K, explaining their significance for investors. The", "url": "https://www.marketbeat.com/stocks/NASDAQ/BLAC/sec-filings/", "source_name": "MarketBeat", "published_at": "2023-10-02T17:09:58", "published_display": "02 Oct 2023 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "South Korean biotech group spies US SPAC as route to Nasdaq", "summary": "South Korean biotech OSR Holdings plans to go public on the Nasdaq through a merger with the US-based SPAC Bellevue Life Sciences Acquisition. OSR, a global healthcare holding company, has oncology and osteoarthritis drug development operations in South Korea and Switzerland. The", "url": "https://www.fiercebiotech.com/biotech/south-korean-biotech-group-spies-us-spac-route-nasdaq", "source_name": "Fierce Biotech", "published_at": "2023-07-12T08:45:00", "published_display": "12 Jul 2023 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "sector", "tier_label": "Sector context"}, {"title": "BLAC - Bellevue Life Sciences Acquisition Corp Latest Stock News & Market Updates", "summary": "This page provides news and updates for Bellevue Life Sciences Acquisition Corp. (BLAC), detailing its transformation into OSR Holdings, Inc. and its subsequent trading as OSRH on Nasdaq. The content highlights key milestones such as the business combination, name change, and OSR", "url": "https://www.stocktitan.net/news/BLAC/", "source_name": "Stock Titan", "published_at": "2023-07-11T20:09:02", "published_display": "11 Jul 2023 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bellevue Life Sciences Acquisition Corp. (BLACU) Prices $60M IPO", "summary": "Bellevue Life Sciences Acquisition Corp. has priced its $60 million IPO, with units expected to trade on Nasdaq under \"BLACU.\" The SPAC intends to target the biotechnology sector within the healthcare industry, focusing on next-generation biologics. This offering adds to the 2023", "url": "https://www.spacinsider.com/news/headline-post/bellevue-life-sciences-prices-60m-ipo", "source_name": "SPACInsider", "published_at": "2023-02-09T17:55:00", "published_display": "09 Feb 2023 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "Form DEF 14A OSR Holdings Inc For: 16 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOMl9rMnJHMy0yRkgzNkxOX3pTSUJPcVlrNlJGZl9nRGFFLWl2cXRkMTVQRkdmNmVBQzVUVjh5OGI1T2xJVnVMVHFkeDVGaktuRHN3TW5RY2Fpb1BQY2ZIQnJSd0c3YklGZkZXanhieWJlb0p1Sjc1cXFwMXZjYWV1Mng2Sml1RmhjNHFaRVFsdlBxZWVNUEJIS2ZBZHJhb2xWTHdtVQ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-16T21:12:05+00:00", "published_display": "16 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSR Health (NASDAQ: OSRH) asks shareholders to approve a 150M share increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOOC1zc0pyMWJsLThfS0NiZEhndHYwS1JFY0FjdFVleFRlMzZNLVlERkFwRjhmdU1DaTlYWmJlbUxPb0JLTkp1LXpiRUNsOG5NbWJ3NzJPV3U0V2FUZDhGUzRWWFZRZFA0dS1vTVZMdHBJTlJtZ1NQempBN2NLc0R6SjAySG5fdEY4Vk1jd05WYmhBeFF3OFdUX082ZlZiWjIwdzVmVXJ3QVhaTFhvTlZLY1dn?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSR Health, Inc. Actuals & Estimates (NASDAQ:OSRH)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNUTVlN2E3ZXAtVjZIRWx4NHFrR2pmWngwRkxMM2JQUGhuZzlzeWprMEh4WW1qeERJY2tTN2FITWdMV3FkWWlwWWl5MlpWSXZHWTFMRFJ0SklOX0lwdDRWdE5McHJ2R0pNWEFaM1ZyUl9mZ0RIMUxrb2ZKN2EwVFFYR1dmeHB2QQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T08:55:26+00:00", "published_display": "26 Jun 2026 08:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "PR Newswire", "published_at": "2025-04-03T07:00:00+00:00", "published_display": "03 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bellevue Life Sciences Acquisition (BLAC) 10K Form and Latest SEC Filings 2026", "summary": "This article provides an overview of OSR Holdings, Inc.'s (NASDAQ: OSRH) SEC filings, highlighting that the company has submitted over 133 documents since 2022. It details different types of SEC filings such as 10-K, 10-Q, and 8-K, explaining their significance for investors. The", "url": "https://www.marketbeat.com/stocks/NASDAQ/BLAC/sec-filings/", "source_name": "MarketBeat", "published_at": "2023-10-02T17:09:58", "published_display": "02 Oct 2023 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BLAC - Bellevue Life Sciences Acquisition Corp Latest Stock News & Market Updates", "summary": "This page provides news and updates for Bellevue Life Sciences Acquisition Corp. (BLAC), detailing its transformation into OSR Holdings, Inc. and its subsequent trading as OSRH on Nasdaq. The content highlights key milestones such as the business combination, name change, and OSR", "url": "https://www.stocktitan.net/news/BLAC/", "source_name": "Stock Titan", "published_at": "2023-07-11T20:09:02", "published_display": "11 Jul 2023 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Bellevue Life Sciences Acquisition Corp. (BLACU) Prices $60M IPO", "summary": "Bellevue Life Sciences Acquisition Corp. has priced its $60 million IPO, with units expected to trade on Nasdaq under \"BLACU.\" The SPAC intends to target the biotechnology sector within the healthcare industry, focusing on next-generation biologics. This offering adds to the 2023", "url": "https://www.spacinsider.com/news/headline-post/bellevue-life-sciences-prices-60m-ipo", "source_name": "SPACInsider", "published_at": "2023-02-09T17:55:00", "published_display": "09 Feb 2023 17:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "industry", "tier_label": "Industry context"}], "sector": [{"title": "Bellevue Life Sciences Acquisition Corp. (BLAC) to Combine with OSR Holdings", "summary": "Bellevue Life Sciences (NASDAQ:BLAC) has entered into a definitive agreement to combine with OSR Holdings, a Korean healthcare holding company. This merger involves a sponsor entity merging with itself, as both Bellevue and OSR share CEO Peter Kuk Hyoun Hwang, who is also the fou", "url": "https://www.spacinsider.com/news/deal-announcements-amendments/bellevue-life-sciences-blac-to-combine-with-osr-holdings", "source_name": "SPACInsider", "published_at": "2023-11-17T11:14:00", "published_display": "17 Nov 2023 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "sector", "tier_label": "Sector context"}, {"title": "South Korean biotech group spies US SPAC as route to Nasdaq", "summary": "South Korean biotech OSR Holdings plans to go public on the Nasdaq through a merger with the US-based SPAC Bellevue Life Sciences Acquisition. OSR, a global healthcare holding company, has oncology and osteoarthritis drug development operations in South Korea and Switzerland. The", "url": "https://www.fiercebiotech.com/biotech/south-korean-biotech-group-spies-us-spac-route-nasdaq", "source_name": "Fierce Biotech", "published_at": "2023-07-12T08:45:00", "published_display": "12 Jul 2023 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "sector", "tier_label": "Sector context"}]}, "total_fetched": 101, "total_relevant": 17, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 15, "score": 50, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 3.3, "count": 8}, {"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 2.12, "count": 5}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.47, "latest_week": "2026-07-17", "one_week_move": 42.3, "four_week_move": 19.2, "twelve_week_move": -32.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.441003, "market_dynamics_buy_signal": false, "relative_strength": -26.813932, "fair_value_gap": -92.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.0761, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+42.3% over one week, +19.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "Stock Titan", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "SPACInsider", "count": 2}, {"label": "Investing.com Canada", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "PR Newswire", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 2}], "events": [{"label": "Earnings", "count": 8}, {"label": "Deals and strategy", "count": 5}, {"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+42.3% over one week, +19.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Form DEF 14A OSR Holdings Inc For: 16 July By Investing.com"}], "updated_at": "2026-07-18T15:15:51.847760+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}